FDA Approves Third COVID Antibody Treatment for Emergency Use
THURSDAY, May 27, 2021 (HealthDay News) — A third antibody treatment designed to keep high-risk COVID-19 patients from winding up in the hospital was approved for emergency use by the U.S. Food and Drug Administration on Wednesday. Importantly, in lab tests the newly authorized drug, dubbed sotrovimab, neutralized the highlyContinue Reading














